Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells ...

A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a ...

Dr Mark Kris discusses the increasing precision of lung cancer therapies and the need for additional testing to find ...

Advances in lung cancer treatment have changed survival in ways that were unimaginable even a decade ago. Targeted drugs, ...

INDIANAPOLIS, Ind. (Ivanhoe Newswire) --- For people battling a certain type of lung cancer, there’s good news. A new targeted therapy is significantly improving lung cancer patient outcomes. The drug ...

In 2026, the spotlight will be on a handful of therapeutic strategies that could change cancer care for patients by offering ...

T cell engagers, including Imdelltra, show promise in small cell lung cancer, outperforming chemotherapy in trials and changing the standard of care. Antibody-drug conjugates like I-DXd and ABBV-706 ...

Despite a significant 48.8% objective response rate and breakthrough therapy status, this regulatory shift reverses years of ...

Jan 20 (Reuters) - Bristol Myers Squibb said on Tuesday it had signed an agreement with Microsoft to use the tech company's ...

INDIANAPOLIS, Ind. – Lung cancer is the leading cause of cancer deaths in the U.S., according to the American Cancer Society. For people battling a certain type of lung cancer, there’s good news. A ...